Where does Abbott Diabetes Care Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abbott Diabetes Care Inc. ranks #571 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abbott Diabetes Care Inc. hold?

Abbott Diabetes Care Inc. holds 788 US utility patents granted between 2015 and 2025, spanning 62 technology areas.

What is Abbott Diabetes Care Inc.'s Innovation Score?

Abbott Diabetes Care Inc. has an Innovation Score of 66.1 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abbott Diabetes Care Inc. focus on?

Abbott Diabetes Care Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 619 patents. Grants appear in 62 CPC subclasses total.

Is Abbott Diabetes Care Inc.'s patent grant rate increasing or decreasing?

Abbott Diabetes Care Inc.'s recent grant velocity is -17% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Abbott Diabetes Care Inc.'s patents?

Abbott Diabetes Care Inc.'s patents average 19.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abbott Diabetes Care Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Abbott Diabetes Care Inc.

USPTO PatentsView assignee record - 788 granted patents across 62 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abbott ranks #571 of 49,997 tracked US assignees by granted-patent volume, with 788 patents across 62 technology areas.

#571
of 49,997 US assignees by volume: Top 1%
by Innovation Score (66.1/100): 19.1
avg claims per patent: -17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R571 · US Corporation #571 · 788 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 788 grants
TOP-DECILE #571/49,997
PHOTO-FINISH Yokogawa Electric
CPC-WIDE A61B · 62 areas
INNOV-STRONG 66.1/100
CLAIMS-RICH 19.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Yokogawa Electric Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bard Access Systems · near

66
Aclara · near

66
Abbott Diabetes Care · this assignee

66
Jabil · near

66
Wisconsin Alumni… · near

66
3D Lighting… · lowest

7

What this shows Abbott's Innovation Score is 66.1/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Abbott's grant cadence moved

Between 2020–2024, Abbott Diabetes Care Inc. received 315 grants versus 381 in 2015–2019 (-17% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2021 at 89 grants and bottomed in 2020 at 39. Lead class A61B accounts for 78.6% of the portfolio across 62 subclasses. Volume neighbours: Alcon Inc. (#567) and Snecma (#575).

Abbott's three-year grant acceleration

From 2019–2021 to 2022–2024, Abbott Diabetes Care Inc. moved from 189 to 187 grants (0.99x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,216. See the growth leaderboard.

Alcon

793
Bally Gaming

792
Gentex

790
Yeti Coolers

789
Yokogawa Electric

788
Abbott Diabetes C… ◀

788
Stmicroelectronic…

787
National Tsing HU…

783
Snecma

783

What this shows Abbott holds 788 patents at rank #571, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbott

By rank, the assignees closest to #571 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Abbott's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abbott, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (66 here).

Aclara Technologies LLC 66 Jabil Inc. 66 Wisconsin Alumni Research Foundation 66 Bard Access Systems, Inc. 66

Similar claim depth

Nearest assignees by average claims per patent (19.1 here).

United Parcel Service OF America, Inc. 19.1 avg Cognex Corporation 19.1 avg Valve Corporation 19.1 avg Ofinno Technologies, LLC 19.1 avg

Abbott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abbott Diabetes Care Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	76	9.6%
2016	85	10.8%
2017	85	10.8%
2018	74	9.4%
2019	61	7.7%
2020	39	4.9%
2021	89	11.3%
2022	73	9.3%
2023	55	7.0%
2024	59	7.5%
2025partial year	92	11.7%

Which technologies does Abbott Diabetes Care Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 619

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 304

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 177

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 159

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 93

G06F - Electric Digital Data Processing 83

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 69

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 61

Y10T - Technical Subjects Covered BY Former US Classification 43

H04W - Wireless Communication Networks 43

Y02D - Climate Change Mitigation Technologies IN Information AND Communication Technologies [ICT], I.E. Information AND Communication Technologies Aiming AT THE Reduction OF Their OWN Energy USE 41

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 23

H01L - Semiconductor Devices NOT Covered BY Class H10 16

H04B - Transmission 16

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 16

Top 15 of 62 technology areas

Where it ranks

Overall rank by patents

#571

of 49,997 tracked assignees

Innovation Score

66.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Abbott Diabetes Care Inc.'s patent record in context - here's where to go next.

Abbott Diabetes Care Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 78.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #571 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abbott Diabetes Care Inc. against Alcon Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 66.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.